European VC Funds

Aquarius Equity is a UK-based venture capital firm with a strong focus on early-stage investments in high-growth companies, particularly those located in the North of England. The firm, established to bridge the venture capital gap in this region, is dedicated to supporting innovative startups that have the potential to scale significantly. Their latest fund, the Aquarius Origin Fund, targets investments of up to £750,000, focusing on sectors like biotechnology, life sciences, and technology. Aquarius Equity's investment strategy emphasizes scalability and sustainability, with a particular interest in companies that align with the UN Sustainable Development Goals. They seek out companies with proven business models and significant growth potential, especially those that have already secured investment from industry-recognized investors. The firm also encourages investments from private individuals through Self Invested Personal Pension (SIPP) schemes, allowing them to invest in early-stage companies traditionally dominated by institutional funds. Aquarius Equity is not just a financial backer but also an active partner, providing strategic support to help startups achieve their growth ambitions. The firm’s commitment to innovation and sustainability positions it as a key player in the venture capital landscape, particularly in the UK’s underserved Northern regions.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

Aravis is a private equity firm based in Zurich, Switzerland, founded in 2001 by Jean-Philippe Tripet. The firm focuses on high-tech growth investments, primarily in the biotech, creative and digital, and industrial high-tech sectors. Aravis has sponsored multiple fund vintages and has deployed over USD 400 million across four funds. Aravis Growth I LP, their latest initiative, targets investments in established, innovative Swiss and European companies with significant growth potential. This fund aims to fill the gap in growth capital in the region by offering strategic advice, access to networks, and capital to accelerate companies through their growth phases​. The team at Aravis is composed of experienced professionals from various backgrounds, including finance, industry, and technology, providing a wealth of knowledge and expertise to support their portfolio companies. Their investment approach also integrates ESG criteria, aligning with several UN Sustainable Development Goals (SDGs).

ARAX Capital Partners, founded in 2007 and based in Vienna, Austria, is a venture capital firm that focuses on early-stage investments across the life sciences and technology sectors. They are particularly invested in Austrian ventures, targeting young, innovative companies, especially those with patentable technology. ARAX is committed to fostering the growth of startups in these fields by providing significant strategic and financial support. The firm's notable investments include Calyxha Biotechnologies, EveliQure Biotechnologies, and Panoptes Pharma, showcasing their emphasis on biotech and life sciences. Additionally, they have invested in technology companies like The MoonVision and crystalsol, a renewable energy company​​. ARAX Capital Partners generally participates in funding rounds ranging from $1 million to $9 million and has made 41 investments to date. They typically lead rounds, indicating their active role in shaping the growth trajectories of their portfolio companies​​. The team at ARAX is led by experienced partners such as Christian Tiringer, Beatrix Schuberth, and Thomas Cimbal, who bring extensive expertise in venture capital and entrepreneurship to the firm​​. This leadership helps ARAX maintain a strong network and high-quality deal flow, positioning them as a key player in Austria’s venture capital landscape. For startups, ARAX Capital Partners is a valuable partner, particularly for those in the early stages of development, looking for both capital and strategic guidance to scale their innovative solutions in the biotech and technology sectors​.

Archimed Group, founded in 2014 and headquartered in Lyon, France, is a leading private equity firm specializing in the healthcare sector. The firm manages around €8 billion in assets and is focused on investing in small to midsize companies across seven key healthcare sectors, including Biopharma, MedTech, and Healthcare IT. Archimed’s strategy involves acquiring majority stakes in companies and working closely with them to accelerate growth, drive innovation, and expand internationally. Archimed has a strong track record, with its funds consistently ranking in the top decile for performance. The firm’s latest fund, MED Platform II, closed at €3.5 billion in 2023, making it the largest healthcare-only private equity fund raised by a European-based firm. This fund is primarily focused on mid-cap companies in Europe and North America, aiming to support healthcare leaders in scaling their operations through strategic acquisitions and capacity expansions. Archimed’s commitment to impact investing is evident through its alignment with sustainable development goals and its EURÊKA Foundation, which supports healthcare-related charitable initiatives. The firm’s unique blend of financial, medical, and operational expertise positions it as a key player in the global healthcare investment landscape.

Aleph VC, founded in 2013 and based in Tel Aviv, specializes in early-stage investments, primarily partnering with Israeli entrepreneurs. With $850 million under management, Aleph focuses on building meaningful companies and impactful global brands across various sectors, including fintech, digital health, cybersecurity, AI, and machine learning. Notable investments by Aleph include Lemonade, a full-stack global insurance company, and Melio, which provides digital payment tools for small businesses. Other prominent portfolio companies include Nexar, a dashcam and edge-AI platform for better driving, and Freightos, a digital freight marketplace. The firm has also seen significant exits, such as the acquisition of Raftt and the public offering of Freightos​. Aleph typically invests between $2 million and $12 million in seed and pre-seed stages, focusing on innovative companies poised for global expansion. The team, led by co-founders Michael Eisenberg and Eden Shochat, leverages their extensive network and expertise to provide strategic guidance and access to global markets, aiming to create long-term value for their portfolio companies.

Arix Bioscience is a global venture capital firm based in London, specializing in biotechnology investments. Founded in 2016, Arix focuses on backing early-stage companies that are developing breakthrough treatments and technologies in the life sciences sector. Their investment strategy targets ventures from late pre-clinical to clinical stages, emphasizing a diversified portfolio to mitigate risks inherent in biotech investments​. The firm has built a robust portfolio that includes companies like Autolus, a developer of CAR-T cell therapies for cancer, and Disc Medicine, which focuses on treatments for hematologic diseases. Arix has also been involved in significant financing rounds, such as the $50 million Series B for Evommune and Ensoma, highlighting their role in advancing innovative biotech startups. Arix operates a permanent capital model, allowing it to support its portfolio companies through market fluctuations without being bound by strict exit timelines. This approach enables them to provide sustained support to their investments, which is critical in the high-risk, high-reward biotech sector.

Arkley Brinc VC is a venture capital firm based in Warsaw, Poland, that focuses on early-stage investments in hardware-enabled startups, particularly in IoT, MedTech, and smart manufacturing sectors. The firm was established as a joint initiative between Arkley, a European pioneer in hardware investments, and Brinc, a global accelerator known for its deep connections in China’s manufacturing hubs. This partnership allows Arkley Brinc to offer startups not only capital but also a wealth of resources for product development, manufacturing, and global distribution. With a fund size of $15 million, Arkley Brinc invests up to $1 million per company, supporting them from the prototype stage through to IPO. The firm’s investments are concentrated in Poland and across Europe, leveraging its strategic networks to help startups scale effectively. Arkley Brinc has a strong track record, with over 50 projects supported and several successful exits and IPOs. The firm’s team consists of serial entrepreneurs and finance professionals with extensive experience in launching and scaling technology businesses. The Arkley Launchpad program is another key initiative, offering a highly individualized acceleration program designed to raise successful funding rounds and drive operational success. This program is tailored to the specific needs of each startup, providing access to a network of partners in prototyping, manufacturing, sales, and investment.

Armilar Venture Partners is a leading venture capital firm based in Lisbon, Portugal, with a strong international presence. Since its founding in 2000, Armilar has focused on early-stage technology-based companies, particularly in sectors where data, digitization, and connectivity are central. Notable investments include OutSystems, Feedzai, and Vawlt, showcasing their commitment to companies driving digital transformation. Armilar specializes in deep-tech investments, supporting startups that leverage cutting-edge technology to address significant societal challenges. They have a hands-on approach, providing not only capital but also strategic guidance to help their portfolio companies scale effectively. Their investment strategy includes focusing on companies with strong intellectual property and significant market potential, often leading funding rounds to ensure their startups have the resources needed for success. Geographically, while Armilar has a strong focus on Portugal, they are open to investing globally, demonstrating flexibility in finding and supporting the best opportunities regardless of location. Their investment strategy is characterized by patience and long-term support, often leading funding rounds and staying engaged through critical growth phases. The firm has a notable team, including Joaquim Rodrigues, the founder, and managing partners like Nuno Leite and Pedro Santos. These leaders bring extensive experience and a deep understanding of both technology and market dynamics, ensuring they can provide valuable support to their portfolio companies.

Artesian Investments, founded in 2004 by Jeremy Colless, Matthew Clunies-Ross, and John McCartney, is a global alternative investment management firm specializing in venture capital, public and private debt, and impact investment strategies. Based in Sydney, the firm has expanded its reach with offices in Melbourne, Adelaide, Shanghai, Jakarta, Singapore, London, and New York​​. Artesian's notable investments include Instaclustr, PouchNATION, and Regrow Ag. They are particularly active in the Asia-Pacific region, managing over $1.22 billion in assets and boasting more than 600 startup investments​ (Artesian)​. Their investment strategy focuses on early-stage ventures across various sectors, including technology, agrifood, medtech, and AI. Artesian also offers a unique "Venture Capital as a Service" (VCaaS) platform, providing customized investment solutions to corporations, government, and family offices​. The firm places a strong emphasis on ESG (Environmental, Social, and Governance) criteria and impact investing, aiming to deliver sustainable returns while addressing critical global challenges. Artesian is a certified B Corp, underscoring their commitment to positive social and environmental impact. Key team members include Jeremy Colless (CEO), Matthew Clunies-Ross (CIO), and Luke Fay (Partner, Australian Venture Capital). Their diversified team spans multiple continents, bringing extensive expertise and a global perspective to their investment activities

Arthur Ventures, established in 2008 and headquartered in Minneapolis, Minnesota, focuses on investing in early-stage B2B software companies across the U.S. and Canada. They emphasize backing startups located outside Silicon Valley, promoting innovation and growth in diverse regions. Arthur Ventures' portfolio includes a variety of successful companies. Notable investments feature DataCamp, an online data science training platform; Protenus, which offers patient data protection; and ThreatLocker, a zero-trust endpoint security solution. Other significant portfolio companies include Jane.app, a practice management software for health and wellness clinics, and CertifID, a network management software company. The firm has made over 102 investments and has seen 18 exits, with companies like Ionic and TINYpulse achieving successful outcomes. Arthur Ventures focuses on sectors such as SaaS, cybersecurity, fintech, and healthcare IT, providing capital and strategic support to help early-stage companies grow and succeed.

Asahi Kasei Ventures is the corporate venture capital arm of Asahi Kasei, a diversified Japanese conglomerate with major operations in materials, homes, and healthcare. The venture fund focuses on early-stage investments globally, with a particular emphasis on startups that align with Asahi Kasei's strategic interests, such as advanced materials, healthcare innovations, and sustainability technologies. The fund is particularly active in sectors like hydrogen energy, carbon management, and bio-based chemicals, supporting startups that contribute to environmental sustainability. Asahi Kasei Ventures operates from key locations including Tokyo, Düsseldorf, and Shanghai, ensuring a broad geographic reach to identify and support innovative technologies worldwide. Asahi Kasei Ventures not only provides financial support but also leverages the vast resources and expertise of the broader Asahi Kasei Group, which has over 287 subsidiaries and a significant global footprint. This enables startups in their portfolio to benefit from deep industry knowledge, extensive networks, and strategic partnerships to accelerate their growth and impact.

Ascension Ventures is a strategic healthcare-focused venture capital firm based in St. Louis, Missouri. Launched in 2001 by Ascension, it manages over $1 billion in assets across five funds. The firm strategically invests in early to late-stage companies within healthcare services, health technology, and medical devices. Its unique approach connects more than 450 healthcare providers, creating an ecosystem that enables startups to directly engage with health system executives, driving solutions that address complex healthcare challenges. Ascension Ventures’ portfolio includes companies like Olive (an AI platform for healthcare administration), EBR Systems, and GetWellNetwork, reflecting its emphasis on technology that enhances clinical outcomes, patient experience, and operational efficiency. The firm typically invests between Series A and B rounds, with capital sizes ranging from $10 to $20 million per company, often seeking board seats or observer rights to guide their portfolio firms. The firm is distinguished by its close ties to 13 major health systems, which represent a network of over 580,000 healthcare professionals. This strategic positioning allows Ascension Ventures not only to provide funding but also to facilitate partnerships and scale innovations that improve healthcare delivery across the United States.

Asimov Ventures is an early-stage venture capital firm with offices in New York City and Palo Alto. The firm focuses on investing in cutting-edge technologies such as 3D printing, robotics, and advanced computing. Asimov Ventures seeks to partner with visionary entrepreneurs dedicated to transforming their industries through innovative solutions. Notable investments by Asimov Ventures include Particle3D, which specializes in 3D-printed bone implants, and Kadena, a blockchain technology company. The firm also invests in various other sectors, including healthcare, e-commerce, and augmented reality, reflecting their broad interest in transformative technologies​. Asimov Ventures typically participates in funding rounds with other notable investors, providing capital and strategic support to help startups scale and succeed. Their investment strategy emphasizes early-stage companies with strong intellectual property and commercial potential​.

Astanor Ventures, founded in 2017 by Eric Archambeau and George Coelho, is a Brussels-based venture capital firm specializing in sustainable agrifood technologies. The firm focuses on investing in early-stage, mission-driven companies that address significant social or environmental issues within the agrifood value chain. This includes sectors like regenerative agriculture, bioeconomy, and climate-positive solutions. Astanor recently closed its second venture fund at €360 million, bringing its total assets under management to €800 million. This fund will support innovative solutions aimed at transforming the global food system to be more sustainable and resilient​. The firm boasts an extensive network of entrepreneurs, experts, scientists, and policymakers, which helps identify and nurture groundbreaking technologies. Notable investments include companies that advance autonomous electric agricultural machinery, high-functioning proteins, and genomic sequencing for sustainable food production.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

AstraZeneca is a leading global biopharmaceutical company with a strong focus on oncology, biopharmaceuticals, and rare diseases. They are committed to discovering, developing, and delivering innovative medicines that transform the lives of patients worldwide. AstraZeneca's oncology portfolio is particularly noteworthy, with a significant emphasis on creating groundbreaking cancer treatments. Their strategy includes leveraging various scientific platforms such as antibody-drug conjugates (ADCs), radioconjugates, and T cell engagers. Recent high-profile deals include collaborations with Daiichi Sankyo for ADCs and the acquisition of Neogene Therapeutics to enhance their T cell receptor therapy capabilities​​. In addition to oncology, AstraZeneca has a robust pipeline in biopharmaceuticals aimed at addressing chronic diseases and enhancing long-term health outcomes. They are also advancing treatments for rare diseases, expanding their reach globally to ensure broader access to their innovative therapies​​. AstraZeneca's business development approach is integral to their growth, focusing on strategic alliances and partnerships. This includes collaborations with companies like Tempus for AI-enabled precision medicine and various biotech firms to accelerate advancements in areas like epigenetics and undruggable targets​​. The company emphasizes a culture of innovation, diversity, and sustainability, aiming to make a significant impact on global health while maintaining environmental responsibility through initiatives like Ambition Zero Carbon​.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

AtmosClear Investments is a Lausanne-based venture capital firm dedicated to accelerating the clean-tech revolution by investing in disruptive technologies that drive sustainability. Established in 2001, AtmosClear focuses on sectors like renewable energy, water purification, sustainable agriculture, and smart city infrastructure. Their diverse portfolio includes companies working on innovative solutions such as large-scale solar and wind energy projects, energy storage, recycling systems, and biofuels, with investments across Europe, particularly the UK and Switzerland. One of their notable ventures is Close the Loop, a recycling company specializing in repurposing ink cartridges, and they have also managed major solar installations in the UK, totaling over 30 MW. The firm’s mission is to generate both financial returns and positive environmental impact, emphasizing the reduction of harmful pollutants like microplastics and greenhouse gases. They support companies at various stages, from early startups to more mature businesses in need of growth capital​. AtmosClear’s team is led by experienced professionals with decades of expertise in finance and private markets. Founder Henry Sykes and his team leverage their deep knowledge to identify opportunities that align with their sustainability ethos. The firm’s global reach is underscored by investments in multiple continents, and they continue to seek out promising clean-tech entrepreneurs who share their vision of a more sustainable future. With a strong emphasis on long-term ecological benefits, AtmosClear is setting a new standard for responsible, impactful investing in the clean-tech space.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

Audacia is a Paris-based private equity and venture capital firm, founded in 2006 by Charles Beigbeder. The firm focuses on a range of investment strategies, including venture capital, growth capital, and buyouts, primarily targeting high-tech, real estate, and consumer sectors. With a strong emphasis on innovation and technological advancement, Audacia has built a diverse portfolio of over 229 investments, including companies like Gamestream and Multiverse Computing. Audacia is particularly active in France, which accounts for the majority of its investments, though they also have a presence in other regions like the United Kingdom. The firm’s approach involves leading early-stage and Series A funding rounds, supporting startups through to later stages of growth. Audacia’s investment philosophy centers on backing visionary entrepreneurs and innovative companies that have the potential to disrupt their respective industries. The firm is led by a seasoned team of 20 professionals, including key figures such as Charles Beigbeder, Cedric James, and Vincent Brillault, who bring extensive experience in both the investment and operational aspects of the business. With its strategic focus and deep expertise, Audacia continues to play a significant role in shaping the European venture capital landscape​.

Auriga Partners is a Paris-based venture capital firm established in 1998. The firm specializes in early-stage investments across various sectors, including information technology, life sciences, and cybersecurity. Auriga Partners has a strong focus on supporting high-potential ventures in Europe, North America, and Israel. Notable investments by Auriga Partners include Vade Secure, Nexthink, and Exeliom Biosciences. Vade Secure, a leader in predictive email defense, and Nexthink, a prominent analytics software provider, highlight Auriga’s commitment to backing innovative tech companies. Exeliom Biosciences, a biotech firm focused on the development of microbiome therapeutics, demonstrates their investment in life sciences. Auriga Partners has a robust portfolio with over 171 investments and 77 exits, reflecting their extensive experience and successful track record in venture capital. Their approach involves not only providing capital but also leveraging their expertise and network to support the growth and development of their portfolio companies. The team at Auriga Partners includes seasoned professionals like Philippe Granger, Mathieu Chatain, and Nabil Gharios, who bring significant industry knowledge and investment experience.

Autotech Ventures, based in Menlo Park, California, is an early-stage venture capital firm with a mission to solve global ground transportation challenges through technology. The firm manages over $500 million and invests in startups from seed to Series C stages that focus on connectivity, autonomy, shared-use, electrification, and digitization of enterprises. Autotech Ventures has an impressive portfolio that includes notable investments such as Lyft, Cazoo, SpotHero, Volta, and Outdoorsy. They have a history of successful exits, including Bear Flag Robotics, acquired by John Deere, and nuTonomy, acquired by Delphi. Their investment strategy often involves initial investments ranging from $1 million to $8 million, and they are known for their deep industry expertise and strong network within the transportation sector. The team, led by managing directors Quin Garcia and Daniel Hoffer, combines decades of experience in both the ground transport and venture capital industries. This allows them to identify and support startups that have the potential to disrupt traditional transportation models or introduce significant innovations in the field. Autotech Ventures prides itself on a founder-first philosophy and actively supports its portfolio companies by leveraging its extensive network of industry insiders, including fleet operators, vehicle manufacturers, and energy companies. This approach not only helps startups gain critical industry connections but also facilitates strategic partnerships and acquisitions.

Avant Global is a relationship-driven private investment firm founded in 1999, focused on leveraging high-level connections to foster innovative and high-growth companies. The firm has a global presence with offices in the USA, Greece, and the Philippines, and invests across various sectors including technology, healthcare, real estate, and consumer products​. Notable portfolio companies include The Healing Company, which focuses on healthcare and retail, Equiam, specializing in venture capital and asset management, and Jawbone Health, an information services and wellness company. Other significant investments are in innovative firms like Iron Ox, a leader in agricultural robotics, and BlueLayer, a software company based in Berlin​. The firm's founder and CEO, Demetri Argyropoulos, is known for his extensive network and strategic vision, having co-founded and invested in over 100 companies. He leads a seasoned team, including Executive Director George Vassilaras, who brings decades of experience in diverse industries and geographies​.

Aves Lair is a global venture capital and venture operator founded in 2020, specializing in supporting early-stage startups in the blockchain, AI, Web3, and digital asset sectors. Initially launched as a technology hub in 2018, Aves Lair has evolved into a comprehensive ecosystem that combines venture capital, acceleration, and hands-on operational support to foster growth and innovation. The firm operates with a “founder-first” approach, offering more than just financial backing. Through its in-house accelerator and incubation programs, Aves Lair captures startups at an early stage, providing critical resources such as fundraising assistance, technical development through in-house engineering teams, and strategic market access. The firm also supports its portfolio companies by securing board seats and guiding them through cross-border expansions. Aves Lair invests in projects that focus on the adoption of digital assets and disruptive technologies, with a strong network across Asia, Africa, and North America. Its portfolio includes companies like Computecoin and Digital Prime Technologies, which benefit from tailored support in everything from product development to scaling in global markets​.

Avid Ventures is a venture capital firm focused on backing early-stage startups in fintech, consumer internet, and software sectors across North America, Europe, and Israel. Founded in 2020 by Addie Lerner, formerly of General Catalyst, Avid invests primarily at Seed, Series A, and Series B stages. With a $68 million debut fund, Avid’s flexible approach allows for varied check sizes, co-leading rounds or making smaller initial investments alongside other top-tier investors. What sets Avid apart is its deep involvement in the strategic growth of its portfolio companies. The team, which includes key members like Tali Vogelstein and Irene Gendelman, works closely with founders, providing hands-on support in areas like financial modeling, business development, hiring, and fundraising strategy. Their approach is highly collaborative, with Avid acting as a dedicated extension of the startup’s team, offering outsourced strategic finance support and helping companies scale operationally. Avid’s portfolio includes a diverse range of innovative companies, such as Rapyd, a global payments platform, Nova Credit, a cross-border credit data provider, and Coast, a fintech startup. The firm is known for its founder-first mentality, emphasizing long-term partnerships and building trust through early involvement and continued support throughout the company's growth journey. This unique blend of flexibility, strategic involvement, and strong partnerships makes Avid Ventures a highly sought-after investor for transformative, high-growth startups.

AXA Venture Partners (AVP) is a global venture capital firm with more than €2 billion in assets under management. Founded in 2015, AVP focuses on investing in high-growth, technology-enabled companies across various stages, from early to late growth. Their investment sectors include enterprise software, fintech/insurtech, digital health, and consumer technology. Notable investments in AVP's portfolio include companies like Phenom People, Security Scorecard, and Virtuo. The firm leverages its connection with AXA, providing portfolio companies access to AXA’s global networks and expertise in risk management and financial services. This unique relationship allows AVP to offer significant business development support, shortening sales cycles and expanding market reach for their portfolio companies. AVP operates globally from offices in New York, London, and Paris. Their investment strategy is characterized by a multi-stage approach, focusing on product-market fit and initial traction in venture stage investments, and seeking companies with robust customer bases and significant revenue growth in growth stage investments. The leadership team includes François Robinet, the founder and managing partner, and other experienced partners such as Elizabeth de Saint-Aignan and Alex Scherbakovsky, who bring extensive expertise in technology and venture capital. For startups, AVP values exceptional founders with innovative solutions that can transform industries. Their support goes beyond financial backing, providing strategic guidance and leveraging their extensive network to help companies grow and succeed.

Axeleo Capital (AXC) is a French-based venture capital firm focused on early-stage investments across Europe. Launched in 2017, the firm is backed by a large network of tech entrepreneurs and is known for its thematic funds targeting specific sectors like B2B SaaS, PropTech, and ConTech. With its AXC2 fund, launched in 2022, the firm expanded into greentech and cybersecurity, providing investment from pre-seed through Series A. AXC typically invests between €500,000 and €1.5 million in pre-seed and seed stages, with larger amounts available for follow-on investments in later rounds. The firm manages over €80 million in assets, with a portfolio of over 35 startups, including notable companies like Formance, Mob Energy, and GarantMe. AXC places strong emphasis on long-term support for its portfolio, offering not only capital but also operational guidance​. AXC's hands-on approach is rooted in the expertise of its founders, Eric Burdier and Mathieu Viallard, and the firm collaborates closely with an ecosystem of industry experts to support founders from inception to growth. The firm focuses on sectors undergoing digital transformation, especially in enterprise software, fintech, and energy solutions.

Axon Partners Group, founded in 2006 and headquartered in Madrid, Spain, is a global investment and consulting firm specializing in technology and innovation. The firm operates across multiple investment strategies, including direct venture capital investments, funds of funds, and growth equity. Axon has a strong presence in Europe, Israel, and the U.S., and it focuses on sectors such as digital, life sciences, deep tech, and sustainable technology. Axon Partners Group has made numerous notable investments. For instance, they invested in ISR, a Spanish technology company specializing in artificial vision systems for quality control in industry. ISR's Specular Vision® technology addresses complex inspection needs for transparent and reflective surfaces in various sectors like automotive and metallurgy. Axon's investment aims to support ISR's international expansion and strengthen its position as a leader in machine vision technology. Other significant investments include Finizens, a wealth management firm offering digital robo-advisory services, and Holaluz, an independent energy company in Spain providing green power and gas to businesses and households. Additionally, Axon has supported companies like Nextmol, which focuses on accelerating the design of new chemicals through molecular modeling and AI, and Glamping Hub, a global platform for unique outdoor accommodations. Axon's investment approach combines financial support with strategic consulting to help portfolio companies scale and innovate. They are committed to sustainability and investing in technologies that drive the transition to a sustainable world.

B Capital Group, founded in 2015 by Eduardo Saverin, Raj Ganguly, and Howard Morgan, is a global multi-stage investment firm. The firm focuses on investing in technology, healthcare, and climate sectors, supporting companies from seed to late-stage growth. With $7+ billion in assets under management, B Capital operates out of eight global locations, including New York, San Francisco, Los Angeles, Singapore, Beijing, and Hong Kong. B Capital's portfolio includes over 160 companies. Notable investments are in firms like Icertis, an AI-powered contract lifecycle management platform; Synack, a crowdsourced cybersecurity testing platform; and Khatabook, a digital bookkeeping solution for small businesses. These investments reflect B Capital's focus on transformative technologies that have the potential to reshape industries. The firm leverages its strategic partnership with Boston Consulting Group (BCG) to provide portfolio companies with expert advice, operational support, and strategic connections, helping them scale efficiently and effectively across global markets. B Capital's recent initiatives include the closure of their third growth fund series at $2.1 billion, emphasizing their commitment to supporting high-growth startups in the enterprise, fintech, and healthcare tech sectors. B Capital's investment approach is characterized by value-add investing, where they offer comprehensive support throughout the business development lifecycle. This includes advisory services on entering new markets, talent acquisition, and strategic business development, ensuring their portfolio companies achieve sustainable growth and success.

Backed VC is a human-centric venture capital firm based in London, known for its early-stage investments across Europe. Since its inception, Backed VC has supported over 80 companies, including notable names like FabricNano, Sky Mavis, Hoxton Farms, and Ruka Hair. The firm typically invests at the Seed stage, with average ticket sizes ranging from €500K to €2.5M. Backed VC’s investment strategy focuses on fostering strong relationships with founders, viewing them as the most crucial asset of any company. They emphasize a collaborative approach, providing extensive support through their proprietary Seed to Series A Founder Development Platform, which offers masterclasses, tools, and services to help founders navigate the complexities of scaling their businesses. This platform assists with everything from hiring to preparing for subsequent funding rounds, emphasizing leadership development and mental health support. The firm operates with a community-centric ethos, creating a robust intra-portfolio network where founders can share experiences and resources. This includes workshops, the BACKED Buddy Programme, and informal gatherings that facilitate deeper connections among portfolio companies.

BackingMinds is a Swedish venture capital firm founded in 2016 with a mission to support startup entrepreneurs who are typically overlooked by traditional VC networks. The firm focuses on identifying and investing in high-potential founders from underrepresented backgrounds, particularly those outside major tech hubs or those not fitting the conventional startup mold. Currently, BackingMinds is investing from its second fund, which has raised around €50 million. The firm has a diversified portfolio, including companies like CemVision in building products, TrusTrace in supply chain traceability, and Transfer Galaxy, a digital remittance platform. These investments reflect BackingMinds' commitment to uncovering and nurturing talent in areas that are often missed by other investors. The team, led by founding partners Sara Wimmercranz and Susanne Najafi, is based in Stockholm and operates with a hands-on approach. They are particularly known for backing women and immigrant-led startups or businesses located outside Sweden's traditional tech ecosystem, including cities beyond Stockholm.

BAE Systems is a global leader in defense, aerospace, and security solutions, employing around 100,000 people across 40 countries. The company focuses on developing advanced technology solutions to protect national security and provide military capability worldwide. BAE Systems' strategy revolves around maintaining and growing its core businesses, which include electronic systems, platforms, and services, while also expanding into emerging markets such as robotics, AI, and cybersecurity. The company is deeply involved in the development of unmanned systems, including autonomous vehicles and drones, which are integrated into tactical communications networks to enhance battlefield effectiveness. The company is also committed to sustainability, with initiatives aimed at achieving net-zero operations by 2030. BAE Systems is investing in innovations that not only enhance military capabilities but also contribute to environmental sustainability, such as energy-efficient platforms and carbon management technologies. In the robotics sector, BAE Systems has been particularly active, filing multiple patents related to unmanned systems and autonomous vehicles, reflecting its focus on maintaining technological superiority in defense and security.

Baidu Ventures is a venture capital firm launched by Baidu in 2016, with a focus on supporting emerging technologies, particularly in artificial intelligence (AI). The firm is headquartered in Beijing, China, and manages over $700 million in assets, with a portfolio of more than 200 active companies worldwide. BV.ai invests in AI-driven industries such as autonomous vehicles, robotics, life sciences, advanced computing, and medical technology. BV.ai is known for being one of the early pioneers in AI venture capital, investing in startups that are developing cutting-edge technologies. The firm primarily targets companies that are at the seed to growth stages, offering capital and strategic guidance to help these businesses scale and achieve significant technological breakthroughs. BV.ai is committed to fostering innovation that can transform industries and have a long-lasting global impact. The firm’s approach includes providing not only financial backing but also technical expertise and resources from Baidu's extensive ecosystem. This gives portfolio companies access to Baidu’s research and development capabilities, helping them stay competitive in fast-evolving markets. BV.ai has successfully supported a variety of startups, including those in the fields of autonomous driving, smart healthcare, and AI-powered enterprise solutions. With a mission to drive the next wave of technological advancements, BV.ai continues to lead the way in AI-focused venture investments, helping entrepreneurs develop groundbreaking solutions that address critical challenges across multiple industries. The firm's strategy is to partner with technology-driven entrepreneurs from the earliest stages, aiming to identify pioneers in various industries. Baidu Ventures not only provides financial backing but also strategic support, leveraging its expertise and Baidu's resources to accelerate growth. Their investments span key sectors such as smart cities, IoT, new energy vehicles, and semiconductors. Led by Xue Gao as CEO and Managing Partner, the firm has gained recognition in China as a top investor in AI and big data, consistently ranking among the best investment institutions in the field. By focusing on long-term value creation, Baidu Ventures aims to foster the development of groundbreaking technologies that can transform industries and improve people's lives globally.

Balderton Capital is a prominent venture capital firm based in London, specializing in early-stage investments across Europe. Established in 2000 as Benchmark Capital Europe, it became independent in 2007 and has since managed over $2.1 billion in funds. The firm focuses on backing technology and internet startups, and has invested in over 230 companies. Notable investments include Betfair, MySQL, Revolut, Depop, and THG (The Hut Group). These companies have achieved significant exits, with Betfair going public in 2010 and MySQL being acquired by Sun Microsystems in 2008. Balderton's current portfolio features innovative companies like GoCardless, ComplyAdvantage, and Darktrace. Balderton Capital operates both early-stage and growth funds, investing between $1 million and $20 million in Series A rounds and up to $50 million in growth stages. The firm has a sector-agnostic approach but typically invests in fintech, health tech, SaaS, and enterprise software. The leadership team includes partners like Bernard Liautaud and Rana Yared, who bring extensive experience and strategic insights. Balderton also offers robust support to its portfolio companies through its "Build with Balderton" platform, which provides resources in talent, marketing, finance, and legal services. Startups looking to partner with Balderton should highlight their potential for significant impact and scalability. The firm values detailed pitches and prefers to be approached through its network​.

Baltic Sandbox Ventures is a Vilnius-based venture capital firm focused on early-stage investments in deep tech and life sciences startups. Founded in 2018, the firm aims to nurture and develop the Baltic region’s ecosystem by backing R&D-driven startups that tackle complex technical challenges with potential for large-scale commercial applications. Their investments span across sectors like AI, biotechnology, cybersecurity, and precision medicine, supporting both software and hardware innovations. With a portfolio of over 23 investments, including companies like Black Swan Space and Biohifas, Baltic Sandbox Ventures typically co-invests with angel investors and other venture funds. The firm offers a range of support through incubation and acceleration programs, providing up to €400,000 in funding to promising startups. Their unique approach involves working closely with scientific founders, ensuring that they have the right team and intellectual property protections in place. Led by general partners Sandra Golbreich, Andrius Milinavičius, and Erik Bhullar, Baltic Sandbox Ventures has positioned itself as one of the most active early-stage investors in the Baltic region, helping to bridge the gap between research and commercial viability​.

Bamboo Capital Partners is a prominent impact investment firm that focuses on delivering both financial returns and social impact. Established in 2007 and headquartered in Luxembourg, Bamboo has invested in over 30 developing countries, particularly targeting sectors such as financial inclusion, clean energy, healthcare, education, and agribusiness. Their notable investments include Bboxx, which provides solar energy and clean cooking solutions in Africa, and Amartha, a fintech platform in Indonesia that connects female entrepreneurs with lenders. Bamboo's investment funds include the ABC Fund, which supports small agribusinesses in Sub-Saharan Africa, and the BUILD Fund, which finances SMEs in the least developed countries. Bamboo's investment strategy involves rigorous due diligence and a focus on companies that improve quality of life and generate employment in low- to middle-income countries. They aim to support businesses with scalable models and significant social impact potential. For startups seeking funding, Bamboo offers a structured application and review process, ensuring that investments align with their impact goals.

Banana Capital, founded by Turner Novak in 2021, is a venture capital firm based in Ann Arbor, Michigan. The firm focuses on early-stage investments across a variety of sectors with a notable emphasis on internet-first and technology-driven companies. Turner Novak, before starting Banana Capital, managed venture capital investments at Gelt VC and Afore Capital​. Banana Capital's investment strategy is characterized by its commitment to backing consumer tech founders and supporting innovative startups through seed funding. The firm's portfolio includes investments in companies like Chainguard, a leader in software supply chain security, Candor, a professional services platform, and Umba, a fintech company focusing on emerging markets​​. The fund has made 50 investments, highlighting its active role in the venture capital landscape. Some recent investments include Packsmith in the logistics sector and Browse AI, which focuses on AI-driven solutions for cloud computing and data integration​​. Banana Capital operates with a philosophy of providing more than just capital. They emphasize strategic guidance and leveraging their extensive network to help startups scale and succeed in competitive markets. The firm has quickly gained recognition for its ability to identify and nurture high-potential startups, becoming a prominent player in the venture capital space.

AVG Basecamp is a venture capital fund managed by Alumni Ventures, known for its extensive network and active investment strategy. Basecamp focuses on pre-seed and seed-stage investments, curating a diversified portfolio across various sectors and geographies. With investments in over 100 startups, AVG Basecamp ensures broad exposure and mitigates risks by reserving 25% of its capital for follow-on investments. Notable investments include companies leveraging advanced science and engineering to address significant tech challenges. The fund operates with a strong geographic presence, with key team members like Catherine Lu and Andrea Funsten based in San Francisco, Matt Scott in New York City, and Wayne Moore in Chicago. This distribution allows AVG Basecamp to access high-potential deals across major venture hubs. AVG Basecamp's investment strategy emphasizes early-stage startups that demonstrate solid traction and potential for rapid growth. The fund prefers a minimum investment of $25K, appealing to accredited investors seeking substantial diversification. AVG Basecamp typically leads funding rounds and actively participates in the growth of its portfolio companies. To approach AVG Basecamp, startups are encouraged to showcase strong early metrics and a capable team. The fund's sourcing process is fueled by its vast network, making personal introductions and network referrals valuable. Investors appreciate the fund's disciplined approach and its commitment to targeted diversification, ensuring a balanced and high-quality venture portfolio.

BASF Venture Capital GmbH (BVC) is the corporate venture arm of BASF, focused on investing in early to mid-stage companies that align with the group's strategic priorities. Established in 2001, BVC targets innovative sectors including decarbonization, circular economy, agricultural technology (AgTech), new materials, digitization, and disruptive business models. Its global presence spans key hubs like Mannheim, Toronto, Boston, Los Angeles, Shanghai, and Sao Paulo, enabling it to connect startups with BASF's extensive network of research, partners, and clients worldwide. BVC manages an evergreen fund of approximately €250 million, which allows for flexibility in investment timelines. Typically, it engages in seed to Series B rounds, emphasizing strategic alignment with BASF’s core business areas. The venture team collaborates closely with portfolio companies, providing not only financial backing but also access to BASF's industry expertise and resources, helping startups scale and penetrate new markets. The firm's portfolio includes diverse ventures such as IntelliSense.io (AI for industrial efficiency), Computomics (predictive breeding in agriculture), and Essentium (industrial 3D printing). Additionally, BVC has invested in various technology funds, including partnerships with accelerators like Alchemist to stay connected with emerging trends and innovations. Led by a team of seasoned professionals across multiple continents, BVC's approach focuses on fostering innovation that contributes to sustainability and future-ready solutions for the chemical and broader industrial sectors.

Battery Ventures, founded in 1983, is a global, technology-focused investment firm with offices in Boston, San Francisco, Menlo Park, New York, London, and Tel Aviv. The firm has invested in over 450 companies, with 69 going public and 185 achieving mergers or acquisitions. Notable portfolio companies include AuditBoard, Nutanix, and Amplitude. Battery Ventures invests across various sectors, including application software, infrastructure software, consumer tech, industrial technologies, and life sciences. The firm's geographic reach and industry diversity allow it to support a wide range of innovative businesses. The investment strategy at Battery Ventures emphasizes both early and growth-stage companies, with a particular focus on majority-growth investments, where they take substantial ownership stakes. This approach helps them provide significant strategic and operational support to their portfolio companies. Battery's typical investments range from seed funding to large buyouts, with recent funds totaling over $3.8 billion. Key team members include Neeraj Agrawal, Michael Brown, and Roger Lee, all of whom bring extensive expertise in scaling technology companies. Their offices span major global tech hubs, ensuring a broad and influential presence in the venture capital landscape. For startups looking to connect with Battery Ventures, demonstrating robust market potential and strategic alignment with Battery’s focus areas can be advantageous. The firm values long-term partnerships and provides not just capital but also strategic guidance to help companies achieve substantial growth.

Baukunst is a venture capital firm dedicated to leading pre-seed investments in companies at the intersection of technology and design. With its inaugural $100 million fund, Baukunst focuses on partnering with creative technologists, often making the first institutional investment that a founding team receives. The firm typically invests between $500,000 and $2 million, aiming to lead every round and take an active role in building companies from the ground up. Baukunst's investment strategy emphasizes high conviction and deep engagement, offering more than just capital. The firm provides hands-on support during the critical early stages of company development, helping with hiring, customer acquisition, and product launch. Their portfolio spans diverse industries, including AI-powered platforms, sustainable energy solutions, and digital health technologies. Led by four general partners with extensive experience in building companies, Baukunst prioritizes companies that push the boundaries of innovation. Their portfolio includes startups like Omnibus (a digital comic platform), DIG Energy (affordable geothermal energy), and Eyebot (AI-driven eye exams). By investing in the early, formative stages, Baukunst partners with founders to transform bold ideas into enduring companies.

BayBG Bayerische Beteiligungsgesellschaft mbH, based in Munich, Germany, is a prominent venture capital and private equity firm focused on supporting medium-sized enterprises and tech startups. With an investment volume exceeding €310 million, BayBG has a diverse portfolio of over 35 tech companies, including NavVis and tado°, and a history of successful exits and follow-on financings. BayBG offers flexible investment options ranging from equity to mezzanine capital, supporting companies across various stages and needs, such as growth financing, succession planning, and restructuring. Their typical initial investments range from €1 million in pre-Series A to €5 million in Series B rounds, with the potential for follow-on investments up to €10 million​. The firm’s strategic approach involves acting as both a lead and co-investor, leveraging its extensive network and transactional experience to enhance the value of its portfolio companies. BayBG prides itself on being an evergreen fund, free from the exit pressures of traditional fund structures, allowing for long-term partnerships with its investees​. Key team members, such as Dr. Marcus Gulder, provide personalized support, ensuring that each investment aligns with BayBG’s goal of sustainable growth and innovation. The firm has been instrumental in driving the success of companies like NavVis, known for its digital twin technology, and memtime, a privacy-focused time-tracking software​.

Bayern Kapital, founded in 1995 and based in Landshut, Germany, is a key venture capital firm focused on supporting high-tech startups and scale-ups in Bavaria. With nearly 30 years of experience, the firm manages around €700 million and has invested in over 320 Bavarian high-tech companies. Bayern Kapital offers investments ranging from €250,000 to €25 million per company, targeting sectors such as biotechnology, medical technology, software and IT, environmental technology, and new materials. The firm's investment approach emphasizes long-term partnerships, acting as a co-investor alongside private investors to support startups through various growth phases from seed to scale-up. Bayern Kapital prides itself on fostering innovation and entrepreneurship in Bavaria, aiming to drive job creation and economic development in the region. Some notable investments in their portfolio include companies like ProGlove, Immunic Therapeutics, and Sphera. Bayern Kapital's strategy is to offer not just financial support but also leverage their extensive network to help startups connect with potential investors, partners, and customers, thereby enhancing their growth prospects. Key team members include Wolfgang Härtl, Investment Director, who leads their dedicated team of over 40 professionals with diverse academic and professional backgrounds, contributing to their robust support system for portfolio companies​.

BayWa r.e. Energy Ventures is a venture capital firm established in 2018 as a part of BayWa r.e., a leading global player in the renewable energy sector. Based in Munich, Germany, the firm focuses on investing in early-stage startups that are driving innovation in the energy industry. BayWa r.e. Energy Ventures targets scalable business models within key areas such as digital energy solutions, energy storage, and e-mobility, with a strong emphasis on supporting the transition to a sustainable energy future. The firm’s investment strategy is deeply rooted in its commitment to fostering the energy transition. By identifying and backing startups with innovative solutions, BayWa r.e. Energy Ventures aims to accelerate the development and adoption of technologies that contribute to decarbonization and the broader goals of sustainability. The firm primarily invests in companies across Europe and Israel, leveraging its extensive industry network and market expertise to provide strategic guidance alongside financial investment. BayWa r.e. Energy Ventures is not just a financial partner; it plays an active role in helping its portfolio companies navigate the complex energy market. The firm offers access to a wide range of resources, including market insights, industry connections, and technical expertise, enabling startups to scale effectively and achieve long-term success. By aligning its investments with the growing demand for clean energy solutions, BayWa r.e. Energy Ventures is at the forefront of supporting the next generation of energy innovators.

BCF Ventures, established in 2018, is a Montreal-based corporate venture capital fund that primarily invests in early-stage technology companies across North America, with selective investments in Europe and Israel. BCF Ventures was founded as a spin-off from BCF Business Law, one of Canada's leading law firms, making it one of the first Canadian venture funds launched by a law firm. BCF Ventures focuses on sectors such as B2B SaaS, cloud computing, artificial intelligence, and healthtech. The firm typically participates in Seed and Series A rounds, with initial check sizes around $125K, and prefers to be a minority investor, retaining pro-rata rights for future follow-on investments. Their investments often range from $1M to $5M in funding rounds, targeting companies with strong unit economics and modest revenue growth. Notable investments include companies like FleetOps in transportation tech, Athennian in enterprise applications, and FightCamp in healthtech. The firm is led by CEO Sergio Escobar and focuses on helping startups scale effectively while maintaining a lean cash burn and achieving at least 18 months of runway per funding round. BCF Ventures has garnered recognition for its diverse portfolio and strategic partnerships, leveraging its ties to BCF Law to offer startups both legal expertise and access to a broad network of industry connections, helping them navigate complex business landscapes as they scale.

BeAble Capital, established in 2016 and headquartered in Madrid, Spain, focuses on early-stage investments in deep science and industrial technologies. Their primary mission is to advance technologies from academic and research institutions into market-ready products, aligning with the United Nations Sustainable Development Goals. BeAble Capital's investment sectors include New Space, New Energy, New Materials, Agro & Food, Environment, Healthcare & Wellbeing, Medtech, Robotics, and AI. Notable investments in their portfolio include companies like Alen Space, which develops small satellites, and A4Cell, which specializes in single-cell monitoring tools. Another significant investment is in Alcyon Photonics, a firm that designs and manufactures photonic integrated circuits. BeAble Capital is led by founders Almudena Trigo, David López, and other partners. They emphasize a hands-on approach in the early development stages, including proof of concept, scale-up, and pre-industrial phases, providing critical support to transform scientific discoveries into commercially viable products. Their strategy involves close collaboration with universities, research centers, and industrial companies to identify promising projects, focusing on technologies that address unmet needs in high-growth markets. The firm has made over 50 investments, reflecting its commitment to fostering innovation and industrial growth in Spain and beyond.

Beast Ventures is a venture capital firm based in London, focusing on early-stage investments in deep tech and transformative technologies. Established in 2015, Beast Ventures targets startups across the UK and Continental Europe that are working on breakthrough engineering, applied science, and technology (hence the acronym BEAST). The firm emphasizes investments in frontier technologies that hold the potential for significant impact in areas such as health, climate, and society. Beast Ventures typically invests at the seed stage, providing support to founders from the inception of their companies through various stages of growth. The firm’s investment portfolio spans diverse industries including artificial intelligence, biotech, cybersecurity, climate tech, and more. Notable investments include companies like Ochre Bio, which focuses on developing RNA therapies for liver disease, and Nutropy, a biotech startup creating sustainable food products. The fund's investment strategy is geared towards achieving outsized returns by backing startups that push the boundaries of science and technology, particularly those with the potential to create significant societal impact. Beast Ventures offers flexible investment sizes, ranging from $100,000 to $2 million, and is known for its deep commitment to supporting cutting-edge innovation​.